Medicinal cannabis companies fined almost $1m by TGA over false treatment claims
Australia's drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy
Medicinal cannabis companies that falsely claimed their prescription products could treat serious conditions, such as cancer and epilepsy, have received a collective fine of almost $1m by Australia's drugs regulator.
The Therapeutic Goods Administration (TGA) issued 73 infringement notices totalling $972,360 between the medicinal cannabis companies MGC Pharmaceuticals Ltd, Cannatrek Ltd and Little Green Pharma Ltd. The infringements were for the alleged unlawful advertising of medicinal cannabis products on websites and social media platforms.
Sign up to receive an email with the top stories from Guardian Australia every morning
Continue reading...